<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human microRNA-9 (miR-9) has been reported to be involved in the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of several <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> including brain <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, its role in the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) remains to be revealed </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we evaluated miR-9 expression in metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and investigated its effects on the motility and proliferation of RKO cells </plain></SENT>
<SENT sid="3" pm="."><plain>The expressions of miR-9 in 15 primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens without distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (NM group) and 10 primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens (M group) with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (M group) were determined by quantitative real-time PCR </plain></SENT>
<SENT sid="4" pm="."><plain>The alternations in the motility and <z:mp ids='MP_0000002'>morphology</z:mp> of RKO cells before and after miR-9 transfection were analyzed by migration assay and F-actin staining </plain></SENT>
<SENT sid="5" pm="."><plain>The relationship between miR-9 and α-catenin was identified by Western blotting </plain></SENT>
<SENT sid="6" pm="."><plain>Cell growth was examined by <z:chebi fb="0" ids="53233">MTT</z:chebi> (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazoliumbromide) assay </plain></SENT>
<SENT sid="7" pm="."><plain>Significant difference of miR-9 expression was observed in M group compared to the NM group (P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Ectopic expression of miR-9 enhanced the motility of RKO cells as well as changed their morphological appearance, while cell growth remained unchanged </plain></SENT>
<SENT sid="9" pm="."><plain>The overexpression of miR-9 could also down-regulate α-catenin expression </plain></SENT>
<SENT sid="10" pm="."><plain>These data suggest that miR-9 may potentially participate in the metastatic process of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> though facilitating cell motility </plain></SENT>
</text></document>